Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
BY WEIGHT
16
# OF OVERLAPPING HOLDINGS
IBBQ
214
HOLDINGS
7%
ALSO IN MEDX
MEDX
28
HOLDINGS
57%
ALSO IN IBBQ
SECTOR DRIFT (IBBQ minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 7.4% | 5.9% | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.6% | 5.5% | 4.6% |
|
ALNYLAM PHARMACEUTICALS INC | 4.1% | 5.9% | 4.1% |
|
REGENERON PHARMACEUTICALS | 6.1% | 2.4% | 2.4% |
|
BIOGEN IDEC INC | 2.1% | 2.5% | 2.1% |
IBBQ Overweight Relative to MEDX
|
GILEAD SCIENCES INC | 7.7% |
|
VERTEX PHARMACEUTICALS INC | 7.7% |
|
REGENERON PHARMACEUTICALS | 3.7% |
|
INSMED INC | 2.0% |
 |
ARGENX SE ADR | 2.0% |
|
SUMMIT THERAPEUTICS INC | 1.7% |
|
ROYALTY PHARMA PLC CLASS A | 1.7% |
|
ILLUMINA INC | 1.7% |
|
AMGEN INC | 1.5% |
 |
SANOFI-AVENTIS-ADR | 1.5% |
IBBQ Underweight Relative to MEDX
|
ELI LILLY & CO | -16.4% |
|
ABBVIE INC | -8.8% |
 |
NOVARTIS AG-ADR | -7.3% |
|
BRISTOL-MYERS SQUIBB CO | -5.2% |
|
JOHNSON & JOHNSON | -4.8% |
|
PFIZER INC | -4.0% |
 |
ALKERMES PLC | -3.7% |
|
MERCK & CO. INC. | -3.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.7% |